EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C25H30N2O4.H2O.HCl |
| Net Charge | 0 |
| Average Mass | 477.001 |
| Monoisotopic Mass | 476.20780 |
| SMILES | Cl.O.[H][C@@]1(c2ccc(C(=O)O)cc2)C[C@@H](OCC)CCN1Cc1c(OC)cc(C)c2nccc12 |
| InChI | InChI=1S/C25H30N2O4.ClH.H2O/c1-4-31-19-10-12-27(22(14-19)17-5-7-18(8-6-17)25(28)29)15-21-20-9-11-26-24(20)16(2)13-23(21)30-3;;/h5-9,11,13,19,22,26H,4,10,12,14-15H2,1-3H3,(H,28,29);1H;1H2/t19-,22-;;/m0../s1 |
| InChIKey | JUWBBUFSAGEROP-VVJLZRNGSA-N |
| Roles Classification |
|---|
| Biological Roles: | immunomodulator Biologically active substance whose activity affects or plays a role in the functioning of the immune system. complement factor B inhibitor Any inhibitor of complement factor B. |
| Application: | immunomodulator Biologically active substance whose activity affects or plays a role in the functioning of the immune system. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| iptacopan hydrochloride monohydrate (CHEBI:229654) has part iptacopan hydrochloride (CHEBI:229653) |
| iptacopan hydrochloride monohydrate (CHEBI:229654) has role complement factor B inhibitor (CHEBI:229655) |
| iptacopan hydrochloride monohydrate (CHEBI:229654) has role immunomodulator (CHEBI:50846) |
| iptacopan hydrochloride monohydrate (CHEBI:229654) is a hydrate (CHEBI:35505) |
| IUPAC Name |
|---|
| 4-{(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl}benzoic acid hydrochloride hydrate |
| Synonyms | Source |
|---|---|
| iptacopan hydrochloride hydrate | KEGG DRUG |
| LNP023 hydrochloride monohydrate | ChEBI |
| LNP 023 hydrochloride monohydrate | ChEBI |
| LNP-023-AAB | DrugBank |
| LNP-023 hydrochloride monohydrate | DrugBank |
| LNP023-AAB | DrugBank |
| Brand Name | Source |
|---|---|
| Fabhalta | DrugBank |
| Manual Xrefs | Databases |
|---|---|
| DBSALT003493 | DrugBank |
| D12252 | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| CAS:2447007-60-3 | ChemIDplus |
| Citations |
|---|